Sotera Health Q2 2024 Adj. EPS $0.19 Beats $0.16 Estimate, Sales $276.594M Beat $266.443M Estimate
Portfolio Pulse from Benzinga Newsdesk
Sotera Health reported its Q2 2024 financial results, with adjusted EPS of $0.19 beating the estimate of $0.16, and sales of $276.594 million surpassing the expected $266.443 million.
August 05, 2024 | 11:02 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sotera Health's Q2 2024 financial results exceeded expectations, with an adjusted EPS of $0.19 beating the $0.16 estimate and sales of $276.594 million surpassing the $266.443 million estimate.
The better-than-expected earnings and sales figures are likely to positively impact SHC's stock price in the short term as they indicate strong financial performance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100